tradingkey.logo

BIO-Key International Inc

BKYI
查看详细走势图
0.618USD
-0.007-1.10%
收盘 12/24, 13:00美东报价延迟15分钟
4.52M总市值
亏损市盈率 TTM

BIO-Key International Inc

0.618
-0.007-1.10%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-1.10%

5天

-3.26%

1月

-25.53%

6月

-26.42%

今年开始到现在

-63.85%

1年

-38.80%

查看详细走势图

TradingKey BIO-Key International Inc股票评分

单位: USD 更新时间: 2025-12-24

操作建议

BIO-Key International Inc当前公司基本面数据相对健康,增长潜力稳定。当前估值合理,在电子设备与零部件行业排名46/58位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价2.00。中期看,股价处于下降通道。近一个月,市场表现非常差,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。

BIO-Key International Inc评分

相关信息

行业排名
46 / 58
全市场排名
354 / 4562
所属行业
电子设备与零部件

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 1 位分析师
买入
评级
2.000
目标均价
+160.01%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

BIO-Key International Inc亮点

亮点风险
BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.
业绩增长期
公司处于发展阶段,最新年度总收入6.93M美元
估值低估
公司最新PB估值0.75,处于3年历史低位
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值36.93K

BIO-Key International Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

BIO-Key International Inc简介

BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.
公司代码BKYI
公司BIO-Key International Inc
CEODepasquale (Michael W)
网址https://www.bio-key.com/

常见问题

BIO-Key International Inc(BKYI)的当前股价是多少?

BIO-Key International Inc(BKYI)的当前股价是 0.618。

BIO-Key International Inc的股票代码是什么?

BIO-Key International Inc的股票代码是BKYI。

BIO-Key International Inc股票的52周最高点是多少?

BIO-Key International Inc股票的52周最高点是3.680。

BIO-Key International Inc股票的52周最低点是多少?

BIO-Key International Inc股票的52周最低点是0.613。

BIO-Key International Inc的市值是多少?

BIO-Key International Inc的市值是4.52M。

BIO-Key International Inc的净利润是多少?

BIO-Key International Inc的净利润为-4.30M。

现在BIO-Key International Inc(BKYI)的股票是买入、持有还是卖出?

根据分析师评级,BIO-Key International Inc(BKYI)的总体评级为买入,目标价格为2.000。

BIO-Key International Inc(BKYI)股票的每股收益(EPS TTM)是多少

BIO-Key International Inc(BKYI)股票的每股收益(EPS TTM)是-0.898。
KeyAI